Home Cart Sign in  
Chemical Structure| 1350653-20-1 Chemical Structure| 1350653-20-1

Structure of Vericiguat
CAS No.: 1350653-20-1

Chemical Structure| 1350653-20-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Vericiguat targets soluble guanylate cyclase (sGC) and is used for treating heart failure.

Synonyms: BAY1021189; Verquvo

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Vericiguat

CAS No. :1350653-20-1
Formula : C19H16F2N8O2
M.W : 426.38
SMILES Code : O=C(OC)NC1=C(N)N=C(C2=NN(CC3=CC=CC=C3F)C4=NC=C(F)C=C42)N=C1N
Synonyms :
BAY1021189; Verquvo
MDL No. :MFCD28502029
InChI Key :QZFHIXARHDBPBY-UHFFFAOYSA-N
Pubchem ID :54674461

Safety of Vericiguat

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Related Pathways of Vericiguat

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT06321094 Acute Coronary Syndrome|Heart ... More >>Failure With Reduced Ejection Fraction Less << PHASE4 RECRUITING 2025-12-01 the First Affiliated Hospital ... More >>of Nanjing Medical University, Nanjing, Jiangsu, China Less <<
NCT06415227 Vasospastic Angina PHASE2 NOT_YET_RECRUITING 2026-06-01 -
NCT06812546 Heart Failure|Acute Myocardial... More >> Infarction (AMI)|Acute Heart Failure (AHF) Less << PHASE4 NOT_YET_RECRUITING 2026-12-30 The First Affiliated Hospital ... More >>of Chongqing Medical University, Chongqing, 400000, China Less <<
NCT06601465 Heart Failure|Cognitive Impair... More >>ment Less << PHASE2 NOT_YET_RECRUITING 2025-05-27 University of Calgary, Calgary... More >>, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada|University of Ottawa, Ottawa, Ontario, Canada|McGill University Health Center, Montreal, Quebec, Canada Less <<
NCT05704478 Heart Failure PHASE4 NOT_YET_RECRUITING 2027-03-31 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.35mL

0.47mL

0.23mL

11.73mL

2.35mL

1.17mL

23.45mL

4.69mL

2.35mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories